Results 221 to 230 of about 7,073,905 (294)

Efficacy and safety of donanemab in the European eligible population: TRAILBLAZER-ALZ 2 post-hoc analyses. [PDF]

J Prev Alzheimers Dis
Jessen F, Dell'Agnello G, Zimmer JA, Sapin C, Dichter S, Doty E, Epelbaum S, Evans CD, Hauck PM, Khanna R, Brooks DA, Sims JR, Agosta F, Alzheimer’s Disease Neuroimaging Initiative (ADNI).   +13 more
europepmc   +1 more source

A comparative life cycle assessment of the environmental impact of preoperative skin preparation, single-use applicators versus bulk antiseptic with reusable instruments. [PDF]

J Infect Prev
Szalecka K, Merrigan E, Forrey R, Kambam V, Boisson M, Yousefzadeh Z, Calistri-Yeh M, Lu D.   +7 more
europepmc   +1 more source

Effect of Mirikizumab on Clinical and Endoscopic Outcomes Based on Prior Advanced Therapy Failure in Patients With Moderately to Severely Active Ulcerative Colitis. [PDF]

United European Gastroenterol J
Hart A, Navabi S, D'Haens G, Matsuoka K, Martín-Arranz MD, Atreya R, Samaan KH, Dhesi E, Redondo I, Zhu B, Paulissen J, Zaremba-Pechmann L, Baygani S, Limdi J, Laharie D, Danese S.   +15 more
europepmc   +1 more source

Multi-country outbreak of <i>Salmonella</i> Bovismorbificans ST377 infections linked to the consumption of alfalfa sprouted seeds 25 June 2026. [PDF]

EFSA J
europepmc   +1 more source

Results from TRIUMPH [EUROPE], a Real-World Observational Study on the 3-Month Effectiveness of Galcanezumab Versus Traditional Oral Migraine Preventive Medications. [PDF]

Pain Ther
Tassorelli C, Novick D, Gonderten S, Vincent M, Robinson RL, Martimianaki G, Pozo Rosich P.   +6 more
europepmc   +1 more source

Bridging circular economy business models and rebound effects: Mapping systemic associations with semantic network analysis. [PDF]

J Ind Ecol
Guzzo D, Pigosso DCA.
europepmc   +1 more source

Agreement: Ida M. Tarbell and The Macmillan Company for Life of Lincoln, January 26, 1920

, 1920
Macmillan Company
core